Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The antibody-drug conjugate Tivdak led to remission in 24% of cervical cancer patients.
Teens can receive the cancer-preventing HPV vaccine at the same time as their COVID-19 vaccine.
The vaccine protects against nine types of human papillomavirus, including those that cause cervical and anal cancer.
Prolonged delays in cancer screening for low-income women during the pandemic threaten to increase existing health disparities.
In a new initiative, the Grammy-winning artist advises Black women to protect their cervical health with annual Pap and HPV tests.
The National Comprehensive Cancer Network publishes a new guide that includes updated patient guidelines for colon and rectal cancers.
The early cancer is detected, the easier it is to treat.
However, other malignancies caused by human papillomavirus, including anal and oral cancers, are on the rise.
Study participants who received Libtayo had a 31% lower risk of death than those treated with chemotherapy.
While researchers try to figure out whether treating early anal tissue changes can prevent cancer, some are investigating treatments.
COVID-19, FDA drug approvals and new approaches to treatment and quality of life stood out among this year’s top stories.
Compared with unvaccinated women, the risk among women vaccinated before age 17 dropped by almost 90%.
New guidelines assert that cervical cancer is best detected by a human papillomavirus test, but some groups disagree.
The American Cancer Society now calls for vaccination of girls and boys starting at age 9.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.